The Minnesota Vikings have a bunch of impending free agents but an NFL insider just provided updates on all of the top ones.

Viking Therapeutics VKTX is set to report fourth-quarter and full-year 2024 earnings on Feb. 5, after market close. Since the ...

The Minnesota Vikings can probably bring Sam Darnold back to the team, though only if he is willing to take a little less ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $34.94 which represents a slight increase of $0.89 or 2.61% from the prior close of $34.05. The stock opened at $33.85 and ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating for Viking Holdings, raising the price target to $58 from $50.

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

That was before quarterback guru Kevin O'Connell arrived in Minnesota. He's made the Vikings a dream destination for any ...

The Professional Football Writers of America have named Minnesota Vikings QB Sam Darnold the NFL's Most Improved Player of ...

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $32.87 which represents a slight increase of $0.22 or 0.67% from the prior close of $32.65. The stock opened at $32.87 and ...